These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 8067721)

  • 1. Elevated serum levels of a 90,000 daltons tumor-associated antigen in cancer and in infection by human immunodeficiency virus (HIV).
    Natoli C; Ortona L; Tamburrini E; Tinari N; Di Stefano P; D'Egidio M; Ghinelli F; Sighinolfi L; D'Ostilio N; Piazza M
    Anticancer Res; 1994; 14(3B):1457-60. PubMed ID: 8067721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular biological assessment methods and understanding the course of the HIV infection.
    Katzenstein TL
    APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor associated glycoprotein-72 (TAG-72) levels in patients with non-malignant and malignant disease.
    Filella X; Molina R; Jo J; Bedini JL; Joseph J; Ballesta AM
    Bull Cancer; 1992; 79(3):271-7. PubMed ID: 1392166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 90K tumor-associated antigen and clinical progression in human immunodeficiency virus infection.
    Iacobelli S; Ullrich A; Tinari N; Ortona L; Tamburrini E; D'Egidio M; Ghinelli F; Sighinolfi L; Piazza M; Chirianni A
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):450-6. PubMed ID: 7583441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 90K (Mac-2 BP) predicts CD4 decline in human immunodeficiency virus-infected patients with CD4 counts above 200 x 10(6) cells/L.
    Tinari N; Natoli C; D'Ostilio N; Ghinelli F; Sighinolfi L; Ortona L; Tamburrini E; Piazza M; Chirianni A; Guerra L; Di Gregorio P; Iacobelli S
    Arch Pathol Lab Med; 1998 Feb; 122(2):178-81. PubMed ID: 9499363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the tumour-associated antigen 90K and cytokines in the circulation of persons infected with human immunodeficiency virus.
    Senaldi G; Peakman M; Natoli C; Hussain MJ; Gallati H; McManus T; Vergani D; Iacobelli S
    J Infect; 1994 Jan; 28(1):31-9. PubMed ID: 8163831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte protein synthesis is increased with the progression of HIV-associated disease to AIDS.
    Caso G; Garlick PJ; Gelato MC; McNurlan MA
    Clin Sci (Lond); 2001 Dec; 101(6):583-9. PubMed ID: 11724643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TPS and CA 15.3 serum values as a guide for treating and monitoring breast cancer patients.
    Giai M; Roagna R; Ponzone R; Biglia N; Sgro L; Perona M; Sismondi P
    Anticancer Res; 1996; 16(2):875-81. PubMed ID: 8687144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum levels of soluble tumor necrosis factor receptors as markers for disease progression of human immunodeficiency virus infection].
    Hattori M; Tateyama M; Oishi T; Miyasaka S; Fukutake K
    Rinsho Byori; 1997 Nov; 45(11):1085-90. PubMed ID: 9396350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum selenium versus lymphocyte subsets and markers of disease progression and inflammatory response in human immunodeficiency virus-1 infection.
    Look MP; Rockstroh JK; Rao GS; Kreuzer KA; Spengler U; Sauerbruch T
    Biol Trace Elem Res; 1997 Jan; 56(1):31-41. PubMed ID: 9152510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of serum melatonin levels in HIV-1-infected individuals' parallel disease progression: correlation with serum interleukin-12 levels.
    Nunnari G; Nigro L; Palermo F; Leto D; Pomerantz RJ; Cacopardo B
    Infection; 2003 Dec; 31(6):379-82. PubMed ID: 14735378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection.
    Mildvan D; Spritzler J; Grossberg SE; Fahey JL; Johnston DM; Schock BR; Kagan J
    Clin Infect Dis; 2005 Mar; 40(6):853-8. PubMed ID: 15736019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of a novel circulating serum 90K antigen in HIV-infected haemophilia patients.
    Longo G; Natoli C; Rafanelli D; Tinari N; Morfini M; Rossi-Ferrini P; D'Ostilio N; Iacobelli S
    Br J Haematol; 1993 Sep; 85(1):207-9. PubMed ID: 8251396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Overproduction of tumor necrosis factor-alpha in African patients with HIV-1 infection, cachexia and low tri-iodothyronine syndrome].
    Tevi-Benissan C; Di Costanzo B; Gresenguet G; Belec L
    Med Trop (Mars); 1997; 57(4):349-52. PubMed ID: 9612774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Natural history of human immunodeficiency virus infection in a cohort of Chilean patients].
    Vial PA; Ferreccio C; Abarca K; Ortiz E; Noriega M; Pérez C; Labarca J; Torres M; Ferrés M; González C; Acuña G
    Rev Med Chil; 1996 May; 124(5):525-35. PubMed ID: 9035503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mannoprotein-induced anti-U937 cell cytotoxicity in peripheral blood mononuclear cells from uninfected or HIV-infected subjects: role of interferon-gamma and tumor necrosis factor-alpha.
    Gomez MJ; Torosantucci A; Quinti I; Testa U; Peschle C; Cassone A
    Cell Immunol; 1993 Dec; 152(2):530-43. PubMed ID: 8258154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum dihydrotestosterone and testosterone concentrations in human immunodeficiency virus-infected men with and without weight loss.
    Arver S; Sinha-Hikim I; Beall G; Guerrero M; Shen R; Bhasin S
    J Androl; 1999; 20(5):611-8. PubMed ID: 10520573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble tumor necrosis factor receptors as surrogate markers for the assessment of zidovudine treatment in asymptomatic HIV-1 infection.
    Godfried MH; van der Poll T; Mulder JW; Weverling GJ; Endert E; Lange JM; Sauerwein HP
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):531-9. PubMed ID: 8548332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immune stimulatory protein 90K increases major histocompatibility complex class I expression in a human breast cancer cell line.
    Natoli C; Iacobelli S; Kohn L
    Biochem Biophys Res Commun; 1996 Aug; 225(2):617-20. PubMed ID: 8753808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavior of serum human major histocompatibility complex class I antigen levels in human immunodeficiency virus-infected patients during antiretroviral therapy: correlation with clinical outcome.
    Murdaca G; Contini P; Setti M; Cagnati P; Villa R; Lantieri F; Indiveri F; Puppo F
    Hum Immunol; 2007 Nov; 68(11):894-900. PubMed ID: 18082568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.